Partnership for AI-accelerated
Compound Screening
We believe that true innovation thrives at the intersection of diverse expertise and shared visions. Across sectors, we work side-by-side with partners to translate natural potential into real-world impact, delivered with exceptional speed, efficiency, and accuracy.
Join the leaders who are already transforming their industries.
Join the leaders who are already transforming their industries.
Sectors
Pharmaceuticals
NYB’s proprietary AI, DTIGN, enhances hit identification and streamlines lead optimization by rapidly screening billions of natural compounds. This reduces R&D timelines and costs, ensuring your drug pipeline is filled with high-potential candidates that move quickly from discovery to clinical trials.
AI-accelerated compound screening
Dietary supplements
As consumer demand for natural, health-enhancing products grows, we identify potent bioactive compounds that help you create supplements offering measurable, trusted benefits
Evidence-based wellness
Functional food
We transform everyday ingredients into functional foods that support health and wellness. Our technology uncovers bioactive compounds that meet modern dietary trends, enabling you to create products that offer targeted health benefits.
Beyond basic nutrition
Beauty & personal care
Today’s audiences seek purity, sustainability, and proven results. We identify natural active ingredients that elevate product performance, resonating with conscientious consumers and setting new benchmarks in care.
Natural, clean, and science-backed
Trusted by Industry Leaders
Partner Stories
Discover how our partners have achieved remarkable milestones by leveraging NYB’s technology and expertise. From accelerated drug discoveries to breakthrough wellness products, see how our collaborations are making a meaningful difference.
Partnership
Nanyang Biologics Announces $1.5 Billion Business Combination with RF Acquisition Corp II to Pursue Nasdaq Listing
Nanyang Biologics announced the signing of a business combination agreement with RF Acquisition Corp II, aiming to bring NYB to the public markets.
Partnership
Powering Life Sciences and Health Innovation - A Global AI Alliance from Singapore
Nanyang Biologics hosts AI4Life Summit 2025 with global partners – NVIDIA, Hewlett Packard Enterprise, and Equinix – to accelerate AI-Driven biomedical innovation
.jpg)
Partnership
NYB.AI and Pnaseer Inc. Announce Strategic Partnership to Advance AI-Powered Hair Regeneration Research
NYB.AI and Pnaseer Inc. have entered a strategic partnership to accelerate hair follicle regeneration research by combining AI-powered compound prediction with advanced bio-nanoparticle drug delivery.
